Aaron Cowen’s Bristol-Myers Squibb BMY Stock Holding History

Aaron Cowen’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-33,800	Closed	-$1.91M	–	103
2024 Q4	$1.91M	Buy	+33,800	New	+$1.89M	0.07%	76
2023 Q1	–	Sell	-3,280	Closed	-$236K	–	99
2022 Q4	$236K	Buy	+3,280	New	+$247K	0.01%	84

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aaron Cowen's BMY Position: Q1 2025 in Review

Aaron Cowen sold out of Bristol-Myers Squibb (BMY) in Q1 2025, closing a stake of 33,800 shares — an estimated $1.91M sold.

Aaron Cowen first reported a position in BMY in Q4 2022 and held it in 2 quarters. The position peaked at $1.91M in Q4 2024. 2,481 funds tracked by Wall St. Rank hold BMY as of Q1 2025.

Aaron Cowen reported no remaining Bristol-Myers Squibb position as of Q1 2025 after selling out during the quarter.
Aaron Cowen sold 33,800 Bristol-Myers Squibb shares in Q1 2025, an estimated $1.91M.
Aaron Cowen first reported a position in Bristol-Myers Squibb in Q4 2022 and held it in 2 quarters.
Aaron Cowen's Bristol-Myers Squibb position peaked at $1.91M in Q4 2024.
2,481 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2025.

Based on Suvretta Capital Management's 13F filing for Q1 2025, filed 15 May 2025.